Boston, MA 02/10/2013 (wallstreetpr) – The shares of Opko Health Inc. (NYSE:OPK) plunged Friday after it issued a statement to handle concerns regarding the sale of stocks by one of its executives Adam Logal, recently sold 50,000 of shares held by him to make up for “pressing” needs due to “family circumstances”. Logal, Opko’s chief accounting officer & treasurer, is serving as the vice president of the company.
According to the statement no other employees or insiders exercised share options in the last year and none such insider plans to dispose of his holding in the coming year, the statement reads.
The statement also revealed that Phillip Frost, CEO Opko Health Inc. (NYSE:OPK) purchased 11.2 million and 383,500 million common shares during 2012 and year 2013 (so far) respectively. Frost and several other officers invested in the $175 million public issue of convertible securities.
The biopharmaceutical company has made a series of acquisitions recently. A large number of its medicines are in the final phase of development, which makes it all set for a “pullback”, in the view of analysts. Frost’s purchases which were made at the lower end of the price range triggered a buying trend in the open market.
Considering the company’s potential for revenue generation, the stock is definitely overvalued at the moment. However many analysts are also wary of the insider trading and bulky share issues by the company. The value of the company’s shares has surged over 60% during the three months ending February 28.
The shares of Opko Health Inc. (NYSE:OPK) were down 4.7% to close at $6.49.
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com
Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither WallStreetPR.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at WallStreetPR.com/Disclaimer.
Published by Brendan Byrne
While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance.
The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor.
He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala.
You may contact Brendan via his email (brendanbyrne@wallstreetpr.com) or his Google+ page (https://plus.google.com/u/0/116608759701551457422).
View more posts
